AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AGIOS PHARMACEUTICALS, INC. Director's Dealing 2013

Jul 23, 2013

31580_dirs_2013-07-23_7941f81c-19cc-42f9-ac83-3c97c7a565e6.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-07-23

Reporting Person: MARAGANORE JOHN (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36000	Direct

Footnotes

F1: Reflects a 1-for-2.75 reverse stock split effected on July 11, 2013.